Rachid Izzar

Head of Global Product Strategy and Commercialization · Biogen

Biotechnology

Rachid Izzar heads global product strategy and commercialization at Biogen, following leadership of its intercontinental business and senior commercial roles at AstraZeneca.

Last reviewed: Nov 2, 2026

Rachid Izzar

Head of Global Product Strategy and Commercialization
Biogen

Last Reviewed: November 2, 2026

Executive Summary

Rachid Izzar heads global product strategy and commercialization at Biogen, following leadership of its intercontinental business and senior commercial roles at AstraZeneca.

Career Highlights

  • Became executive vice president for global product strategy and commercialization in July 2021.
  • Joined Biogen in October 2019 to lead its Intercontinental Region and global biosimilars unit.
  • Previously led AstraZeneca’s French business and global cardiovascular franchise.

Professional Journey

Izzar held a series of international commercial and strategy positions at AstraZeneca. As vice president for commercial international operations, his remit included China, Australia, Brazil, Russia, Latin America, Asia, Turkey, the Middle East and Africa.

He later worked in Shanghai on strategic transformation and China portfolio responsibilities. As global vice president of the cardiovascular franchise, he worked across the North American subsidiary, Europe and China. His AstraZeneca career also included the country presidency in France, where his responsibilities extended to both commercial and manufacturing operations.

In October 2019, Izzar joined Biogen as president of the Intercontinental Region and leader of the global biosimilars unit. The regional remit included Latin America, Australia, Asia, Japan, the Middle East and Africa, Turkey and Russia.

Biogen appointed Izzar executive vice president, head of global product strategy and commercialization in July 2021 and added him to its executive committee.

Education

Izzar holds an MBA from the University of Sherbrooke in Canada. He also completed Harvard Business School’s Enterprise Executive Transformation Program.